TScan Therapeutics
TCRX
TCRX
92 hedge funds and large institutions have $55.4M invested in TScan Therapeutics in 2025 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
7.86% less ownership
Funds ownership: 84.59% → 76.73% (-7.9%)
56% less capital invested
Capital invested by funds: $126M → $55.4M (-$70.8M)
Holders
92
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$2.62M | |
| 2 | +$665K | |
| 3 | +$361K | |
| 4 |
Millennium Management
New York
|
+$319K |
| 5 |
JPMorgan Chase & Co
New York
|
+$274K |
Top Sellers
| 1 | -$5.99M | |
| 2 | -$404K | |
| 3 | -$352K | |
| 4 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
-$335K |
| 5 |
TAM
Tocqueville Asset Management
New York
|
-$323K |
